Loading…

Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis

Purpose: To report and analyze the outcomes of therapeutic deep anterior lamellar keratoplasty (DALK) in patients with advanced Acanthamoeba keratitis (AK). Methods: Medical records of microbiologically confirmed AK, underwent DALK from 2004 to 2017, were reviewed and the data related to early and l...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of ophthalmology 2020-03, Vol.68 (3), p.442-446
Main Authors: Bagga, Bhupesh, Garg, Prashant, Joseph, Joveeta, Mohamed, Ashik, Kalra, Paavan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323
cites cdi_FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323
container_end_page 446
container_issue 3
container_start_page 442
container_title Indian journal of ophthalmology
container_volume 68
creator Bagga, Bhupesh
Garg, Prashant
Joseph, Joveeta
Mohamed, Ashik
Kalra, Paavan
description Purpose: To report and analyze the outcomes of therapeutic deep anterior lamellar keratoplasty (DALK) in patients with advanced Acanthamoeba keratitis (AK). Methods: Medical records of microbiologically confirmed AK, underwent DALK from 2004 to 2017, were reviewed and the data related to early and late outcome including complications were retrieved. Outcome of cases with largest diameter of infiltrate ≥8 mm at the time of surgery (advanced keratitis) were analyzed and compared with those with less severe keratitis (infiltrate size less than 8 mm). Results: Out of 23 patients of AK in whom DALK was performed, ten (43.4%) patients had advanced keratitis. Mean age of these patients was 38.7 ± 8.6 years (range, 25 to 56). Median visual acuity at presentation was 2.78 (IQR, 1.79-3.0) that improved to 1.79 (IQR, 0.70-2.78) postoperatively. Early complications included recurrence of AK in 2 (20%), Descemet's membrane detachment in 5 (50%), and persistent epithelial defect in 3 (30%) cases. Overall, 6 (60%) grafts failed, whereas 4 (40%) patients had clear graft at their last follow-up. Median follow-up of these cases was 5 months (IQR, 1.4-11.4). One graft developed stromal rejection, which resolved with increased dose of corticosteroids. In comparison, DALK performed for less severe keratitis (N = 13) had 1 (7.6%) recurrence and 2 (15.8%) grafts failure (OR, 8.25). The probability of one-year graft survival and eradication of infection was 32% and 74.1%, respectively, in advanced cases compared to 91.6% and 83.9% in less severe cases. Conclusion: Outcome of DALK in advanced Acanthamoeba keratitis is less favorable compared to those carried out for less severe keratitis cases.
doi_str_mv 10.4103/ijo.IJO_307_19
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a250a07bc41240eab05d06c0aedaeb44</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A614062383</galeid><doaj_id>oai_doaj_org_article_a250a07bc41240eab05d06c0aedaeb44</doaj_id><sourcerecordid>A614062383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323</originalsourceid><addsrcrecordid>eNp9ksFv0zAUhyMEYmVw5YgiceGS8hw7TnJBqqYBhUm7wBFZL_ZL6zaJi5Os2n-PQ7uNooF8iPTy-Uv88y-KXjOYCwb8vd24-fLLteKQK1Y-iWasLIuEy6J8Gs2AA0tEzouz6EXfbwB4zsrieXTGU8hkAGfRj-tx0K6l2NXxsCaPOxoHq2NDtIuxG8hb5-MGW2oa9PE2EIPbNdgPt7HtYjQ32Gky8UIHeI2towoPlB1s_zJ6VmPT06vj8zz6_vHy28Xn5Or60_JicZVomeVjkgpGKVBqZMo5Z5VBjlrWWgArhQlTWad5JoVIGVQFcYMgdSU1EmV5zVN-Hi0PXuNwo3betuhvlUOrfg-cXyn04VgNKUwzQMgrLVgqgLCCzAQbIBmkSojg-nBw7caqJaOpGzw2J9LTN51dq5W7UTkIzorpZ94dBd79HKkfVGt7PeXXkRt7lfIsK0VeAA_o27_QjRt9F6KaKCkg55A9UCsMB7Bd7cJ39SRVC8kEhNSKyZU8Qq2oC5fRuI5qG8Yn_PwRPixDrdX_26C963tP9X0mDNRURhXKqB7KGDa8-TPJe_yufQH4egD2rglN67fNuCevArvt3P4fWhVqoI6tVa5Wd63lvwDYzfYI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2356407305</pqid></control><display><type>article</type><title>Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Bagga, Bhupesh ; Garg, Prashant ; Joseph, Joveeta ; Mohamed, Ashik ; Kalra, Paavan</creator><creatorcontrib>Bagga, Bhupesh ; Garg, Prashant ; Joseph, Joveeta ; Mohamed, Ashik ; Kalra, Paavan</creatorcontrib><description>Purpose: To report and analyze the outcomes of therapeutic deep anterior lamellar keratoplasty (DALK) in patients with advanced Acanthamoeba keratitis (AK). Methods: Medical records of microbiologically confirmed AK, underwent DALK from 2004 to 2017, were reviewed and the data related to early and late outcome including complications were retrieved. Outcome of cases with largest diameter of infiltrate ≥8 mm at the time of surgery (advanced keratitis) were analyzed and compared with those with less severe keratitis (infiltrate size less than 8 mm). Results: Out of 23 patients of AK in whom DALK was performed, ten (43.4%) patients had advanced keratitis. Mean age of these patients was 38.7 ± 8.6 years (range, 25 to 56). Median visual acuity at presentation was 2.78 (IQR, 1.79-3.0) that improved to 1.79 (IQR, 0.70-2.78) postoperatively. Early complications included recurrence of AK in 2 (20%), Descemet's membrane detachment in 5 (50%), and persistent epithelial defect in 3 (30%) cases. Overall, 6 (60%) grafts failed, whereas 4 (40%) patients had clear graft at their last follow-up. Median follow-up of these cases was 5 months (IQR, 1.4-11.4). One graft developed stromal rejection, which resolved with increased dose of corticosteroids. In comparison, DALK performed for less severe keratitis (N = 13) had 1 (7.6%) recurrence and 2 (15.8%) grafts failure (OR, 8.25). The probability of one-year graft survival and eradication of infection was 32% and 74.1%, respectively, in advanced cases compared to 91.6% and 83.9% in less severe cases. Conclusion: Outcome of DALK in advanced Acanthamoeba keratitis is less favorable compared to those carried out for less severe keratitis cases.</description><identifier>ISSN: 0301-4738</identifier><identifier>EISSN: 1998-3689</identifier><identifier>DOI: 10.4103/ijo.IJO_307_19</identifier><identifier>PMID: 32056998</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Acanthamoeba ; acanthamoeba keratitis ; Acanthamoeba Keratitis - diagnosis ; Acanthamoeba Keratitis - surgery ; Acuity ; Adult ; Analysis ; Corneal transplantation ; Corticosteroids ; deep anterior lamellar keratoplasty ; Edema ; Eye Infections, Parasitic - diagnosis ; Eye Infections, Parasitic - surgery ; Eye surgery ; Female ; Graft rejection ; Graft Survival ; Health aspects ; Humans ; Infections ; Keratitis ; Keratoplasty, Penetrating - methods ; Male ; Medical prognosis ; Medical records ; microbial keratitis ; Middle Aged ; Original ; Patients ; Postoperative period ; Retrospective Studies ; Surgery ; Time ; Visual Acuity</subject><ispartof>Indian journal of ophthalmology, 2020-03, Vol.68 (3), p.442-446</ispartof><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2020 Indian Journal of Ophthalmology 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323</citedby><cites>FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043182/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2356407305?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32056998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bagga, Bhupesh</creatorcontrib><creatorcontrib>Garg, Prashant</creatorcontrib><creatorcontrib>Joseph, Joveeta</creatorcontrib><creatorcontrib>Mohamed, Ashik</creatorcontrib><creatorcontrib>Kalra, Paavan</creatorcontrib><title>Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis</title><title>Indian journal of ophthalmology</title><addtitle>Indian J Ophthalmol</addtitle><description>Purpose: To report and analyze the outcomes of therapeutic deep anterior lamellar keratoplasty (DALK) in patients with advanced Acanthamoeba keratitis (AK). Methods: Medical records of microbiologically confirmed AK, underwent DALK from 2004 to 2017, were reviewed and the data related to early and late outcome including complications were retrieved. Outcome of cases with largest diameter of infiltrate ≥8 mm at the time of surgery (advanced keratitis) were analyzed and compared with those with less severe keratitis (infiltrate size less than 8 mm). Results: Out of 23 patients of AK in whom DALK was performed, ten (43.4%) patients had advanced keratitis. Mean age of these patients was 38.7 ± 8.6 years (range, 25 to 56). Median visual acuity at presentation was 2.78 (IQR, 1.79-3.0) that improved to 1.79 (IQR, 0.70-2.78) postoperatively. Early complications included recurrence of AK in 2 (20%), Descemet's membrane detachment in 5 (50%), and persistent epithelial defect in 3 (30%) cases. Overall, 6 (60%) grafts failed, whereas 4 (40%) patients had clear graft at their last follow-up. Median follow-up of these cases was 5 months (IQR, 1.4-11.4). One graft developed stromal rejection, which resolved with increased dose of corticosteroids. In comparison, DALK performed for less severe keratitis (N = 13) had 1 (7.6%) recurrence and 2 (15.8%) grafts failure (OR, 8.25). The probability of one-year graft survival and eradication of infection was 32% and 74.1%, respectively, in advanced cases compared to 91.6% and 83.9% in less severe cases. Conclusion: Outcome of DALK in advanced Acanthamoeba keratitis is less favorable compared to those carried out for less severe keratitis cases.</description><subject>Acanthamoeba</subject><subject>acanthamoeba keratitis</subject><subject>Acanthamoeba Keratitis - diagnosis</subject><subject>Acanthamoeba Keratitis - surgery</subject><subject>Acuity</subject><subject>Adult</subject><subject>Analysis</subject><subject>Corneal transplantation</subject><subject>Corticosteroids</subject><subject>deep anterior lamellar keratoplasty</subject><subject>Edema</subject><subject>Eye Infections, Parasitic - diagnosis</subject><subject>Eye Infections, Parasitic - surgery</subject><subject>Eye surgery</subject><subject>Female</subject><subject>Graft rejection</subject><subject>Graft Survival</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Infections</subject><subject>Keratitis</subject><subject>Keratoplasty, Penetrating - methods</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>microbial keratitis</subject><subject>Middle Aged</subject><subject>Original</subject><subject>Patients</subject><subject>Postoperative period</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Time</subject><subject>Visual Acuity</subject><issn>0301-4738</issn><issn>1998-3689</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ksFv0zAUhyMEYmVw5YgiceGS8hw7TnJBqqYBhUm7wBFZL_ZL6zaJi5Os2n-PQ7uNooF8iPTy-Uv88y-KXjOYCwb8vd24-fLLteKQK1Y-iWasLIuEy6J8Gs2AA0tEzouz6EXfbwB4zsrieXTGU8hkAGfRj-tx0K6l2NXxsCaPOxoHq2NDtIuxG8hb5-MGW2oa9PE2EIPbNdgPt7HtYjQ32Gky8UIHeI2towoPlB1s_zJ6VmPT06vj8zz6_vHy28Xn5Or60_JicZVomeVjkgpGKVBqZMo5Z5VBjlrWWgArhQlTWad5JoVIGVQFcYMgdSU1EmV5zVN-Hi0PXuNwo3betuhvlUOrfg-cXyn04VgNKUwzQMgrLVgqgLCCzAQbIBmkSojg-nBw7caqJaOpGzw2J9LTN51dq5W7UTkIzorpZ94dBd79HKkfVGt7PeXXkRt7lfIsK0VeAA_o27_QjRt9F6KaKCkg55A9UCsMB7Bd7cJ39SRVC8kEhNSKyZU8Qq2oC5fRuI5qG8Yn_PwRPixDrdX_26C963tP9X0mDNRURhXKqB7KGDa8-TPJe_yufQH4egD2rglN67fNuCevArvt3P4fWhVqoI6tVa5Wd63lvwDYzfYI</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Bagga, Bhupesh</creator><creator>Garg, Prashant</creator><creator>Joseph, Joveeta</creator><creator>Mohamed, Ashik</creator><creator>Kalra, Paavan</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200301</creationdate><title>Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis</title><author>Bagga, Bhupesh ; Garg, Prashant ; Joseph, Joveeta ; Mohamed, Ashik ; Kalra, Paavan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acanthamoeba</topic><topic>acanthamoeba keratitis</topic><topic>Acanthamoeba Keratitis - diagnosis</topic><topic>Acanthamoeba Keratitis - surgery</topic><topic>Acuity</topic><topic>Adult</topic><topic>Analysis</topic><topic>Corneal transplantation</topic><topic>Corticosteroids</topic><topic>deep anterior lamellar keratoplasty</topic><topic>Edema</topic><topic>Eye Infections, Parasitic - diagnosis</topic><topic>Eye Infections, Parasitic - surgery</topic><topic>Eye surgery</topic><topic>Female</topic><topic>Graft rejection</topic><topic>Graft Survival</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Infections</topic><topic>Keratitis</topic><topic>Keratoplasty, Penetrating - methods</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>microbial keratitis</topic><topic>Middle Aged</topic><topic>Original</topic><topic>Patients</topic><topic>Postoperative period</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Time</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bagga, Bhupesh</creatorcontrib><creatorcontrib>Garg, Prashant</creatorcontrib><creatorcontrib>Joseph, Joveeta</creatorcontrib><creatorcontrib>Mohamed, Ashik</creatorcontrib><creatorcontrib>Kalra, Paavan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library (ProQuest Database)</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Indian journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bagga, Bhupesh</au><au>Garg, Prashant</au><au>Joseph, Joveeta</au><au>Mohamed, Ashik</au><au>Kalra, Paavan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis</atitle><jtitle>Indian journal of ophthalmology</jtitle><addtitle>Indian J Ophthalmol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>68</volume><issue>3</issue><spage>442</spage><epage>446</epage><pages>442-446</pages><issn>0301-4738</issn><eissn>1998-3689</eissn><abstract>Purpose: To report and analyze the outcomes of therapeutic deep anterior lamellar keratoplasty (DALK) in patients with advanced Acanthamoeba keratitis (AK). Methods: Medical records of microbiologically confirmed AK, underwent DALK from 2004 to 2017, were reviewed and the data related to early and late outcome including complications were retrieved. Outcome of cases with largest diameter of infiltrate ≥8 mm at the time of surgery (advanced keratitis) were analyzed and compared with those with less severe keratitis (infiltrate size less than 8 mm). Results: Out of 23 patients of AK in whom DALK was performed, ten (43.4%) patients had advanced keratitis. Mean age of these patients was 38.7 ± 8.6 years (range, 25 to 56). Median visual acuity at presentation was 2.78 (IQR, 1.79-3.0) that improved to 1.79 (IQR, 0.70-2.78) postoperatively. Early complications included recurrence of AK in 2 (20%), Descemet's membrane detachment in 5 (50%), and persistent epithelial defect in 3 (30%) cases. Overall, 6 (60%) grafts failed, whereas 4 (40%) patients had clear graft at their last follow-up. Median follow-up of these cases was 5 months (IQR, 1.4-11.4). One graft developed stromal rejection, which resolved with increased dose of corticosteroids. In comparison, DALK performed for less severe keratitis (N = 13) had 1 (7.6%) recurrence and 2 (15.8%) grafts failure (OR, 8.25). The probability of one-year graft survival and eradication of infection was 32% and 74.1%, respectively, in advanced cases compared to 91.6% and 83.9% in less severe cases. Conclusion: Outcome of DALK in advanced Acanthamoeba keratitis is less favorable compared to those carried out for less severe keratitis cases.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>32056998</pmid><doi>10.4103/ijo.IJO_307_19</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-4738
ispartof Indian journal of ophthalmology, 2020-03, Vol.68 (3), p.442-446
issn 0301-4738
1998-3689
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a250a07bc41240eab05d06c0aedaeb44
source Publicly Available Content Database; PubMed Central
subjects Acanthamoeba
acanthamoeba keratitis
Acanthamoeba Keratitis - diagnosis
Acanthamoeba Keratitis - surgery
Acuity
Adult
Analysis
Corneal transplantation
Corticosteroids
deep anterior lamellar keratoplasty
Edema
Eye Infections, Parasitic - diagnosis
Eye Infections, Parasitic - surgery
Eye surgery
Female
Graft rejection
Graft Survival
Health aspects
Humans
Infections
Keratitis
Keratoplasty, Penetrating - methods
Male
Medical prognosis
Medical records
microbial keratitis
Middle Aged
Original
Patients
Postoperative period
Retrospective Studies
Surgery
Time
Visual Acuity
title Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A41%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20of%20therapeutic%20deep%20anterior%20lamellar%20keratoplasty%20in%20advanced%20Acanthamoeba%20keratitis&rft.jtitle=Indian%20journal%20of%20ophthalmology&rft.au=Bagga,%20Bhupesh&rft.date=2020-03-01&rft.volume=68&rft.issue=3&rft.spage=442&rft.epage=446&rft.pages=442-446&rft.issn=0301-4738&rft.eissn=1998-3689&rft_id=info:doi/10.4103/ijo.IJO_307_19&rft_dat=%3Cgale_doaj_%3EA614062383%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c657u-241e20e2d623331bda3ac6fc40194dd626f275644210b8e3da06cb6caee57f323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2356407305&rft_id=info:pmid/32056998&rft_galeid=A614062383&rfr_iscdi=true